Clinical Trials Browser

Gestational Trophoblastic Disease × camrelizumab × 1 year × Clear all

NCT05139095 2026-02-05

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Phase 2 Recruiting

Gestational Trophoblastic Disease